24 HR Rotigotine 0.0417 MG/HR Transdermal System

Known as: ROTIGOTINE 1MG/24HRS PATCH [VA Product], rotigotine 1 MG/Day 24HR Transdermal System, ROTIGOTINE 1MG/24HRS PATCH 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2003-2016
0120032016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Rotigotine behenate (RGTB), a long chain alkyl ester of the prodrug of rotigotine (RGT), has been synthesized for use in a… (More)
Is this relevant?
2016
2016
BACKGROUND AND PURPOSE Dopamine agonists in Parkinson's disease (PD) are associated with impulse control disorders (ICDs) and… (More)
  • table 2
  • figure 1
  • table 3
  • figure 2
  • table 4
Is this relevant?
2013
2013
Currently available dopaminergic drugs such as levodopa and dopamine (DA) receptor agonists impart considerable improvement in… (More)
  • figure 1
  • figure 3
  • figure 2
  • table 1
  • figure 4
Is this relevant?
2004
2004
Purpose. The aim of this study was to characterize the influence of pH and NaCl concentration on the transdermal iontophoretic… (More)
  • figure 2
  • table I
  • figure 1
  • table II
  • figure 3
Is this relevant?
Review
2003
Review
2003
Schwarz Pharma AG, under license from Aderis Pharmaceuticals Inc, is developing rotigotine CDS, a once-daily transdermal patch… (More)
Is this relevant?